NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 724983 | Null | 0.0295480456086945 | 0.33070948 |
NSC 725047 | 5,6-Dihydro-5,11-dioxo-5-(propyl-3'-t-butoxycarbamoyl)-11H-i ndeno[1,2-c]isoquinoline | 0.0295480456086945 | -0.13057187 |
NSC 727486 | Null | 0.0295480456086945 | -0.17312462 |
NSC 735403 | Null | 0.0295480456086945 | 0.4967186 |
NSC 751830 | 2-(4-hydroxypiperidin-1-yl)-4-(4-morpholinophenylamino)pyrido[4,3-d]pyrimidin-5(6H)-one | 0.0295480456086945 | -0.17805756 |
NSC 759852 | Vorinostat (USAN) | 0.0295480456086945 | 0.16328194 |
NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0295480456086947 | 0.32560799 |
NSC 133118 | 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) | 0.0295480456086947 | 0.066353734 |
NSC 176328 | Ellipticine, 6-(3-aminopropyl)-, dihydrochloride | 0.0295480456086947 | 0.34451771 |
NSC 21683 | Null | 0.0295480456086947 | 0.49440058 |